Evidence map›Paper›PMID 37040897›Full record

ArticleJournal of proteome research2023

High-Field Asymmetric Waveform Ion Mobility Spectrometry: Practical Alternative for Cardiac Proteome Sample Processing.

Lizhuo Ai, Aleksandra Binek, Simion Kreimer, Matthew Ayres, Aleksandr Stotland, Jennifer E Van Eyk

Open access · hybridAbstract read
In one paragraph

Article in Journal of proteome research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Proteomics of the heart.Physiological reviews · 2024
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lizhuo AiDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0001-5449-9888
Aleksandra BinekAdvanced Clinical Biosystems Research Institute, Smidt Heart institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Simion KreimerAdvanced Clinical Biosystems Research Institute, Smidt Heart institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0001-6627-3771
Matthew AyresAdvanced Clinical Biosystems Research Institute, Smidt Heart institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Aleksandr StotlandAdvanced Clinical Biosystems Research Institute, Smidt Heart institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0003-4794-1097
Jennifer E Van EykDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0001-9050-148X
Cedars-Sinai Medical Center · US

Funding

SCLERODERMA-ASSOCIATED PAHP50HL084946 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HASSOUN, PAUL M. · 2007 to 2011
$20.6M
Genomic and Proteomic Architecture of AtherosclerosisR01HL111362 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HERRINGTON, DAVID MCLEOD · 2012 to 2021
$17.2M
Exosome Therapeutics to Dissect HFpEF MechanismsR01HL155346 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI MARBAN, EDUARDO, VAN EYK, JENNIFER E · 2021 to 2024
$3.3M
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to ObesityU01DK124019 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI SOBHANI, KIMIA, VAN EYK, JENNIFER E · 2019 to 2022
$3.1M
Regulation of the Dynamic Proteome after Ischemic InjuryR01HL144509 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI GOTTLIEB, ROBERTA A., VAN EYK, JENNIFER E · 2019 to 2022
$2.9M
NHLBI NIH HHS P50 HL084946NHLBI NIH HHS R01 HL111362NHLBI NIH HHS R01 HL144509NHLBI NIH HHS R01 HL155346NIDDK NIH HHS U01 DK124019
6 · The paper itself

Abstract

Heart tissue sample preparation for mass spectrometry (MS) analysis that includes prefractionation reduces the cellular protein dynamic range and increases the relative abundance of nonsarcomeric proteins. We previously described "IN-Sequence" (IN-Seq) where heart tissue lysate is sequentially partitioned into three subcellular fractions to increase the proteome coverage more than a single direct tissue analysis by mass spectrometry. Here, we report an adaptation of the high-field asymmetric ion mobility spectrometry (FAIMS) coupled to mass spectrometry, and the establishment of a simple one step sample preparation coupled with gas-phase fractionation. The FAIMS approach substantially reduces manual sample handling, significantly shortens the MS instrument processing time, and produces unique protein identification and quantification approximating the commonly used IN-Seq method in less time.

Indexed as

Ion Mobility SpectrometryProteomeProteomicsSpecimen HandlingTandem Mass SpectrometryProteomeDIA-MSFAIMSheart tissueIN-Seqin sequence fractionationLC-MS/MSproteomics analysis

Identifiers

PMID37040897
PMCPMC10243111
OpenAlexW4364355783

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.